News
Investment firms in Boston and New York could see the biggest gains from the sale of a Raleigh drugmaker. Raleigh pharma ...
9h
MONTCO Today on MSNWSJ: Merck Makes $10 Billion Move as Keytruda Patent Expiration NearsMerck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for the Wall ...
The pharmaceutical industry is staring down a major patent cliff, with key drugs from Merck (MRK), Bristol Myers Squibb (BMY), and Johnson & Johnson (JNJ) set to lose exclusivity by 2030. Yahoo ...
Pharmaceutical titan Merck & Co. Inc. has announced a landmark $10 billion acquisition of Verona Pharma plc, underscoring its ...
For the third time in four years, CNBC has ranked North Carolina as “America’s Top State for Business” in 2025.
US Foods Holding stock hit an all-time high Friday on a report that the firm was mulling an acquisition of Performance Food ...
17hon MSNOpinion
Barely a day passes without intellectual property nurtured and supported in Britain passing into overseas hands.
Bank of America Securities analyst Jason Gerberry reiterated a Sell rating on ProKidney yesterday and set a price target of $1.00. The company’s shares opened today at $4.82. Take advantage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results